We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
Cap. Flow
+$505M
Cap. Flow %
0.65%
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$83.5M
2
SPGI icon
S&P Global
SPGI
+$73.5M
3
TSLA icon
Tesla
TSLA
+$55.8M
4
MSFT icon
Microsoft
MSFT
+$45.9M
5
AMZN icon
Amazon
AMZN
+$27.9M

Sector Composition

Rank Sector Weight
1 Technology 24.74%
2 Financials 13.53%
3 Healthcare 13.01%
4 Consumer Discretionary 11.66%
5 Industrials 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIRT icon
1651
Virtu Financial
VIRT
$4.93B
$2.74M ﹤0.01%
73,625
-5,861
-7% -$194K
WSBC icon
1652
WesBanco
WSBC
$4B
$2.73M ﹤0.01%
79,334
-7,343
-8% -$265K
NVRI icon
1653
Enviri
NVRI
$620M
$2.72M ﹤0.01%
222,466
-311
-0.1% -$4.57K
GCO icon
1654
Genesco
GCO
$422M
$2.72M ﹤0.01%
42,789
-2,464
-5% -$160K
DFIN icon
1655
Donnelley Financial Solutions
DFIN
$1.16B
$2.72M ﹤0.01%
81,778
-1,736
-2% -$61.9K
CBZ icon
1656
CBIZ
CBZ
$2.96B
$2.71M ﹤0.01%
64,627
-4,649
-7% -$182K
ATSG
1657
DELISTED
Air Transport Services Group
ATSG
$2.71M ﹤0.01%
81,027
-6,565
-7% -$192K
FOLD
1658
DELISTED
Amicus Therapeutics
FOLD
$2.71M ﹤0.01%
285,906
-26,692
-9% -$250K
NTUS
1659
DELISTED
Natus Medical Inc
NTUS
$2.7M ﹤0.01%
102,873
-1,409
-1% -$34.4K
MWA icon
1660
Mueller Water Products
MWA
$4.16B
$2.7M ﹤0.01%
209,006
-33,753
-14% -$436K
NMRK icon
1661
Newmark Group
NMRK
$2.63B
$2.69M ﹤0.01%
169,286
+7,676
+5% +$125K
SCSC icon
1662
Scansource
SCSC
$1.12B
$2.69M ﹤0.01%
77,437
+948
+1% +$31.3K
HZO icon
1663
MarineMax
HZO
$788M
$2.68M ﹤0.01%
66,536
+315
+0.5% +$14.8K
PAG icon
1664
Penske Automotive Group
PAG
$14.2B
$2.66M ﹤0.01%
28,385
-3,635
-11% -$368K
RSP icon
1665
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
$2.66M ﹤0.01%
16,858
-2,086
-11% -$325K
EFC
1666
Ellington Financial
EFC
$1.71B
$2.65M ﹤0.01%
149,445
+9,534
+7% +$168K
MCHB
1667
Mechanics Bancorp
MCHB
$3.68B
$2.65M ﹤0.01%
55,879
-1,991
-3% -$102K
CNNE icon
1668
Cannae Holdings
CNNE
$649M
$2.65M ﹤0.01%
110,604
-8,525
-7% -$240K
ARCH
1669
DELISTED
Arch Resources, Inc.
ARCH
$2.64M ﹤0.01%
19,246
-1,705
-8% -$202K
CARS icon
1670
Cars.com
CARS
$660M
$2.63M ﹤0.01%
182,453
-5,200
-3% -$79.9K
NNI icon
1671
Nelnet
NNI
$4.7B
$2.63M ﹤0.01%
30,970
-1,720
-5% -$148K
NKLA
1672
DELISTED
Nikola Corporation Common Stock
NKLA
$2.63M ﹤0.01%
8,187
+488
+6% +$124K
BHE icon
1673
Benchmark Electronics
BHE
$2.96B
$2.63M ﹤0.01%
104,962
-614
-0.6% -$15.7K
KFRC icon
1674
Kforce
KFRC
$1.06B
$2.63M ﹤0.01%
35,517
-818
-2% -$58.3K
SAFE
1675
DELISTED
Safehold Inc.
SAFE
$2.63M ﹤0.01%
47,372
+1,445
+3% +$89.5K

Similar funds

RhumbLine Advisers's Q1 2022 Portfolio in Review

As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
  • RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
  • RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
  • RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
  • RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
  • RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.

Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.